Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Accepts healthy volunteers

Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers

ClinicalTrials.gov ID: NCT00039975

Public ClinicalTrials.gov record NCT00039975. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 8:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of Potential Pharmacokinetic Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers

Study identification

NCT ID
NCT00039975
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
32 participants

Conditions and interventions

Interventions

  • Amlodipine Drug
  • Diltiazem HCl Drug
  • Indinavir sulfate Drug
  • Ritonavir Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Mar 31, 2004
Last update posted
Oct 31, 2021

Ends 2004

United States locations

U.S. sites
9
U.S. states
7
U.S. cities
9
Facility City State ZIP Site status
Univ of California San Francisco San Francisco California 94110
Stanford Univ Med Ctr Stanford California 943055107
Univ of Colorado Health Sciences Ctr Denver Colorado 80262
Johns Hopkins Hosp Baltimore Maryland 21287
Univ of Minnesota Minneapolis Minnesota 55455
Washington Univ (St. Louis) St Louis Missouri 63108
Cornell Univ Med Ctr New York New York 10021
Univ of Rochester Medical Center Rochester New York 14642
Univ of Cincinnati Cincinnati Ohio 452670405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00039975, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2021 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00039975 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →